Valerie Paradis Selected Research

Valerie Paradis Research Topics

Disease

11	Fibrosis (Cirrhosis) 01/2022 - 06/2002
10	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2010
9	Neoplasms (Cancer) 11/2019 - 09/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 06/2002
3	Liver Diseases (Liver Disease) 10/2021 - 09/2008
3	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2020 - 11/2014
3	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2013
3	Chronic Hepatitis C 12/2016 - 09/2008
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2017
2	Adenoma (Adenomas) 01/2020 - 05/2004
1	Inflammation (Inflammations) 01/2022
1	Hepatitis C 01/2022
1	Cholestasis 10/2021
1	Hepatitis 03/2021
1	Infections 01/2021
1	COVID-19 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Adenocarcinoma 11/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 10/2017
1	Morbid Obesity 01/2017
1	Primitive Neuroectodermal Tumors (PNET) 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 05/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015
1	Glucose Intolerance 05/2015
1	Fatty Liver 05/2015
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 03/2013
1	Cholangiocarcinoma 01/2013
1	Portal Hypertension 07/2012
1	Insulin Resistance 08/2007
1	Atherosclerosis 06/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2011
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 08/2007
3	LY-2157299IBA 01/2021 - 08/2015
3	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 09/2010
3	Messenger RNA (mRNA)IBA 10/2010 - 06/2002
2	CollagenIBA 01/2022 - 08/2012
2	CateninsIBA 01/2020 - 11/2014
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 08/2015
2	ChemokinesIBA 01/2019 - 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	ProcollagenIBA 01/2022
1	Ointments (Pastes)IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	Protons (Proton)IBA 01/2021
1	CaspasesIBA 01/2021
1	Ketamine FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	Hepatocyte Nuclear FactorsIBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Janus KinasesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Gemcitabine FDA Link 11/2019
1	NucleosidesIBA 11/2019
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2019
1	Chemokine CCL11IBA 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019
1	Interleukin-33IBA 01/2019
1	AlarminsIBA 01/2019
1	Chemokine CXCL10IBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2019
1	NeurotensinIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016
1	IronIBA 12/2016
1	Everolimus FDA Link 01/2016
1	Adenosine Triphosphate (ATP)IBA 08/2015
1	Vasopressins (Vasopressin)IBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	CholesterolIBA 05/2015
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 05/2015
1	Pyruvic Acid (Pyruvate)IBA 05/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2015
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 11/2014
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2014
1	GlypicansIBA 11/2014
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 11/2014
1	Cyclin D1IBA 06/2013
1	Small Interfering RNA (siRNA)IBA 06/2013
1	Caspase 3 (Caspase-3)IBA 03/2013
1	Syntex adjuvant formulationIBA 11/2012
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 07/2012
1	Keratin-18 (Keratin 18)IBA 07/2012
1	Vasoconstrictor AgentsIBA 07/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2008
1	Alanine Transaminase (SGPT)IBA 09/2008
1	Connective Tissue Growth FactorIBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2019 - 10/2010
2	Liver Transplantation 10/2017 - 09/2014
1	Drug Therapy (Chemotherapy) 11/2019
1	Bariatric Surgery 01/2017
1	Hepatectomy 01/2013
1	Intravenous Injections 07/2012
1	Radiofrequency Ablation 06/2008